Catalent Biologics Content

  1. Catalent Capabilities Update March 2026: Analytical Services 3/24/2026

    A biologics analytics leader showcases development, testing, and characterization capabilities, emphasizing quality, regulatory compliance, and integrated support from discovery to commercialization.

  2. Rapid Antibody Gene-To-Drug Substance 3/20/2026

    Accelerate your monoclonal antibody program with an integrated gene-to-drug substance platform that delivers GMP-ready material for IND submission and first-in-human studies while ensuring scalability and manufacturing readiness.

  3. Process Optimization For Monoclonal Antibody (mAb) Commercial Manufacturing 3/20/2026

    Get access to the tools and expertise needed to support process development for biologic therapies from the clinical trial phase to commercialization.

  4. Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right 3/3/2026

    This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.

  5. Contract GMP Biologics Analytical Services 7/28/2025

    Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.

  6. Catalent Capacity Update April 2025: Fill/Finish 4/25/2025

    This presentation highlights how simplified execution with development, filling, and analytics under one roof ensures safe, efficacious products reach patients in need.

  7. Leveraging Advanced Technology And Proven Expertise 4/22/2025

    By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.

  8. Formulation Through Manufacturing Under One Roof 2/18/2025

    Partner with a CDMO that understands the unique challenges of emerging biopharma, providing expert guidance in formulation development, manufacturing, and regulatory navigation.

  9. Exploring New And Improved Analytical Methods For Traditional And Unique Modalities 1/2/2025

    Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

  10. Using Novel Biological Responses For Robust Cell-Based Potency Assays 12/2/2024

    Ensure the potency and efficacy of your biologic products with a GMP-compliant potency bioassay, offering accurate real-time assessments for GMP release and stability testing.